Evaluation of Hi-Fatigue G Bone Cement With Gentamicin A Retrospective Data Collection
| Registry | NCT06699134 |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Enrollment | 90 (Estimated) |
| Sponsor | Zimmer Biomet (Industry) |
| Conditions | Total Hip and Knee Arthroplasties |
| Interventions | Total knee arthroplasty, Total Hip arthroplasty (Device) |
| Dates | start 2024-11-19, primary completion 2026-10-01 (estimated), completion 2026-10-01 (estimated), first posted 2024-11-21, last updated 2025-12-02 |
| Locations | 1 site in Germany |
Related Papers Related Patents Related Grants Related Experts
All trials for Total Hip and Knee Arthroplasties All trials of Total knee arthroplasty All trials of Total Hip arthroplasty
The objective of this retrospective monocentric study is to collect survivorship and clinical data confirming safety, performance and clinical benefits for the Hi-Fatigue G Bone Cement.
The assessments will include:
* Radiological analysis performed at different time points according to the standard of care of the hospital
* Implant survivorship and safety based on removal of a study device
* Patient reported outcome measures (PROMs)
Primary endpoint:
Assessment of radiolucent lines around the components (tibial, femoral, acetabular) at 5 years (in accordance with the hospital standard of care).
Secondary endpoints:
* Evaluation of implant survivorship and safety by monitoring the frequency and incidence of adverse events. Relation of the events to implant, instrumentation and/or procedure should be specified.
* Evaluation of PROMs
* Obtain information regarding the cementing technique and handling of the cement, if available
| Arm | Type | Interventions | Description |
|---|---|---|---|
| Patients with TKA | Device: Total knee arthroplasty | Patients with primary total knee replacement using Hi-Fatigue G Bone Cement and a Zimmer Biomet implant | |
| Patients with THA | Device: Total Hip arthroplasty | Patients with primary total hip replacement using Hi-Fatigue G Bone Cement and a Zimmer Biomet implant |
Sex: All, ages: 18 Years to any
Inclusion Criteria: * Subject qualified for cemented TKA or THA with a Zimmer Biomet implant * Subject is willing and able to give written informed consent for retrospective data collection and undergo interim and final evaluation (X-Ray \& Scores completion) * Subject > 18 years old Exclusion Criteria: * Muscle wasting * Neuromuscular compromise in the affected limb * Known hypersensitivity to any of the cement constituents * Subjects with severe renal failure * Bilateral interventions * Subject is a vulnerable subject (prisoner, mentally incompetent or unable to understand what participation to the study entails, known alcohol or drug abuser, anticipated to be non-compliant)
| Facility | City | Country | Status |
|---|---|---|---|
| Klinikum Weiden | Weiden, Bavaria | Germany | Recruiting |